Todd C. Zankel
Nessuna posizione attualmente
Storia della carriera di Todd C. Zankel
Precedenti posizioni note di Todd C. Zankel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Direttore Tecnico/Scientifico/R&S | 01/10/2009 | 01/10/2009 |
| Fondatore | 01/10/2009 | 01/10/2009 | |
| BIOMARIN PHARMACEUTICAL INC. | Direttore Tecnico/Scientifico/R&S | 01/01/1997 | 01/01/2005 |
| RAPTOR PHARMACEUTICAL CORP | Fondatore | 29/09/2009 | - |
| Raptor Pharmaceutical, Inc. | Direttore Tecnico/Scientifico/R&S | 01/01/2006 | - |
| Fondatore | 24/11/2010 | - |
Formazione di Todd C. Zankel
| The Reed Institute | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 3 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Aziende private | 3 |
|---|---|
| Raptor Pharmaceutical, Inc. | Health Technology |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Health Technology |
- Borsa valori
- Insiders
- Todd C. Zankel
- Esperienza
